Co-translational, post-translational, and non-catalytic roles of N-terminal acetyltransferases

H Aksnes, R Ree, T Arnesen - Molecular cell, 2019 - cell.com
Recent studies of N-terminal acetylation have identified new N-terminal acetyltransferases
(NATs) and expanded the known functions of these enzymes beyond their roles as ribosome …

Do post-translational modifications influence protein aggregation in neurodegenerative diseases: a systematic review

LN Schaffert, WG Carter - Brain sciences, 2020 - mdpi.com
The accumulation of abnormal protein aggregates represents a universal hallmark of
neurodegenerative diseases (NDDs). Post-translational modifications (PTMs) regulate …

NAC guides a ribosomal multienzyme complex for nascent protein processing

AM Lentzsch, D Yudin, M Gamerdinger… - Nature, 2024 - nature.com
Approximately 40% of the mammalian proteome undergoes N-terminal methionine excision
and acetylation, mediated sequentially by methionine aminopeptidase (MetAP) and N …

NATs at a glance

H Aksnes, N McTiernan, T Arnesen - Journal of Cell Science, 2023 - journals.biologists.com
Most proteins receive an acetyl group at the N terminus while in their nascency as the result
of modification by co-translationally acting N-terminal acetyltransferases (NATs). The N …

N-terminal acetylation of α-synuclein slows down its aggregation process and alters the morphology of the resulting aggregates

R Bell, RJ Thrush, M Castellana-Cruz, M Oeller… - Biochemistry, 2022 - ACS Publications
Parkinson's disease is associated with the aberrant aggregation of α-synuclein. Although the
causes of this process are still unclear, post-translational modifications of α-synuclein are …

Spreading of α-synuclein and tau: A systematic comparison of the mechanisms involved

E Vasili, A Dominguez-Meijide… - Frontiers in molecular …, 2019 - frontiersin.org
Alzheimer's disease (AD) and Parkinson's disease (PD) are age-associated
neurodegenerative disorders characterized by the misfolding and aggregation of alpha …

Mechanisms of alpha-synuclein toxicity: An update and outlook

IC Brás, M Xylaki, TF Outeiro - Progress in brain research, 2020 - Elsevier
Alpha-synuclein (aSyn) was identified as the main component of inclusions that define
synucleinopathies more than 20 years ago. Since then, aSyn has been extensively studied …

[HTML][HTML] Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology

AR Esteves, AM Palma, R Gomes, D Santos… - … et Biophysica Acta (BBA …, 2019 - Elsevier
Protein post-translational modifications (PTMs) that potentiate protein aggregation have
been implicated in several neurological disorders, including Alzheimer's (AD) and …

Selective vulnerability in α-synucleinopathies

J Alegre-Abarrategui, KR Brimblecombe… - Acta …, 2019 - Springer
Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy are
neurodegenerative disorders resulting in progressive motor/cognitive deficits among other …

Neurons and glia interplay in α-synucleinopathies

P Mavroeidi, M Xilouri - International journal of molecular sciences, 2021 - mdpi.com
Accumulation of the neuronal presynaptic protein alpha-synuclein within proteinaceous
inclusions represents the key histophathological hallmark of a spectrum of …